Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-2 Long Term Studies: Comparison of Available Data

Dorr et al. 1996 10 days 10 Melanogenesis, erections None No chronic dosing pattern Wessells et al. 2000 20 Tanning, erectile function, BP Acute only (2hr post-dose) No sustained BP tracking University of Arizona 2006 60 days Eumelanin, MED Longest published t

This comparison does not assign a generated winner or score.

  • Dorr et al. 1996
  • 10 days
  • 10
  • Melanogenesis, erections
  • None
  • No chronic dosing pattern
  • Wessells et al. 2000
  • 20
  • Tanning, erectile function, BP
  • Acute only (2hr post-dose)
  • No sustained BP tracking
  • University of Arizona 2006
  • 60 days
  • Eumelanin, MED
  • Longest published trial. Still under 9 weeks
  • Netherlands Case Series 2019
  • 6–18 months
  • 14
  • Dermatoscopic changes in nevi
  • Observational only
  • Retrospective. No baseline measurements
  • The table makes the problem clear: even the longest controlled trial (60 days) wouldn't capture the effects most relevant to typical use patterns, and the only data approaching real-world use comes from uncontrolled case reports.
More references

Related material